Disease Development Suppliers Serving Australia

Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...

InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...

betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...

MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR. We provide a secure, scalable, and fast solution that helps thousands of researchers around the globe to discover new drugs and therapies. We develop ...

MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Founded in 2013, MedGenome currently has a Next Generation Sequencing (NGS) ...

LOEWE was established in 1988 as an independent, privately owned company. As one of the commercial pioneers in the plant disease detection sector, the company started with the distribution of antisera for ELISA detection of plant viruses, produced ...

Dawei Veterinary Medical (Jiangsu) Co., Ltd. specializes in the development, production, and marketing of advanced veterinary medical equipment. Established in 2006, the company has quickly evolved into a prominent domestic leader in high-tech ...

IDEXX BioAnalytics customized testing solutions, meaningful data, and global expertise in research testing services. We are constantly working on solutions that help push the industry forward and produce reliable, consistent results while making it ...

GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...

At Bal Seal Engineering, we make custom seals, springs, and electrical contacts that improve the performance and reliability of critical equipment used everywhere – from deep sea to deep space. Although they’re often measured in millimeters, our ...

We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...

Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients ...

Novel point-of-care diagnostics for earlier disease detection. SANO Diagnostics is developing a range of disposable, cost-effective point-of-care diagnostics to detect the early onset of inflammation in several disease states. We are a development ...

InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues. Our unique integration of cell & tissue ...

At TannerMedico A/S, our aim is to help you sleep comfortable, breathe easier and live healthier. We truly believe that any good treatment aims at killing the cause and not just the symptoms. We are a Scandinavian company with the corporate ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...

Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...

DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...